Evidence map›Paper›PMID 30794552›Full record

ArticlePloS one2019

Involvement of premacular mast cells in the pathogenesis of macular diseases.

Takaki Sato, Seita Morishita, Taeko Horie, Masanori Fukumoto, Teruyo Kida, Hidehiro Oku, Kimitoshi Nakamura, Shinji Takai, Denan Jin, Tsunehiko Ikeda

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Fibrotic Changes in Rhegmatogenous Retinal Detachment.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Immune Cells in Subretinal Wound Healing and Fibrosis.Frontiers in cellular neuroscience · 2022
    Review
  4. Article
  5. Article
  6. Involvement of Anoikis in Dissociated Optic Nerve Fiber Layer Appearance.International journal of molecular sciences · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Takaki SatoDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Seita MorishitaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Taeko HorieDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Masanori FukumotoDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Teruyo KidaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Hidehiro OkuDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Kimitoshi NakamuraNakamura Eye Clinic, Matsumoto-City, Nagano, Japan.
Shinji TakaiDepartment of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, Takatsuki-City, Osaka, Japan.ORCID 0000-0003-3963-3983
Denan JinDepartment of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Tsunehiko IkedaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.ORCID 0000-0001-5654-0282
Osaka Medical and Pharmaceutical University · JPThe Nakamura Hajime Eastern Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported on the elevated intravitreal activities of tryptase and chymase in association with idiopathic epiretinal membrane (ERM) and idiopathic macular hole (MH). In this present study, we investigated the potential intraocular production of these serine proteases, and measured and compared tryptase and chymase activities in the vitreous body and serum in ERM, MH, proliferative diabetic retinopathy (PDR), and rhegmatogenous retinal detachment (RRD) patients. In addition, nuclear staining with hematoxylin and eosin (H&E) and mast-cell staining with toluidine blue were performed on samples of the vitreous core and bursa premacularis (BPM) of MH. We also performed immunostaining on the above two regions of vitreous samples for MH with anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, anti-lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) antibody, and anti-fibroblast antibody. Moreover, we performed immunostaining with anti-tryptase antibody and anti-chymase antibody on ERMs collected intraoperatively. Tryptase activity in the vitreous body was significantly higher in ERM and MH than in PDR. However, no significant differences were observed in the tryptase activity in the serum among these four diseases. Chymase activity in the vitreous body was significantly higher in MH than in the other three diseases, yet chymase activity in the serum was below detection limit in any of the diseases. Nuclear staining with H&E revealed an abundance of nuclei in the BPM region, but few in the surrounding area. Mast-cell staining with toluidine blue revealed that the BPM showed metachromatic staining. In immunostaining with anti-fibroblasts antibody, anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, and anti-LYVE-1 antibody, the BPM stained more strongly than the vitreous core. Tryptase and chymase-positive cells were also observed in ERM. These findings revealed that the presence of mast cells in the BPM potentially represent the source of these serine proteases. Moreover, the BPM, as a lymphatic tissue, may play an important role in the pathogenesis of macular disease.

Indexed as

AgedChymasesDiabetic RetinopathyEpiretinal MembraneFemaleHumansImmunohistochemistryMacula LuteaMaleMast CellsMiddle AgedRetinal DetachmentRetinal DiseasesRetinal PerforationsTryptasesVitreous BodyChymasesTryptases

Identifiers

PMID30794552
PMCPMC6386310
OpenAlexW2917545491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.